Drug Profile
Ertiprotafib
Alternative Names: PTP 112Latest Information Update: 13 Jun 2002
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antihyperglycaemics; Carboxylic acids; Naphthalenes; Small molecules
- Mechanism of Action Protein-tyrosine-phosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 13 Jun 2002 Discontinued - Phase-II for Type-2 diabetes mellitus in Europe (unspecified route)
- 13 Jun 2002 Discontinued - Phase-II for Type-2 diabetes mellitus in USA (unspecified route)
- 06 Jun 2002 Ertiprotafib is the INN name for PTP 112